Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database
Arthritis Res Ther. 2026 Feb 28. doi: 10.1186/s13075-026-03774-1. Online ahead of print. NO ABSTRACT PMID:41764518 | DOI:10.1186/s13075-026-03774-1
